Form EFFECT Tempest Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tempest Therapeutics (TPST) files for 9.53M share offering by selling stockholders
- NatureU® BeautyU Becomes the First Oral Beauty Formula Combining PQQ and Ergothioneine to Be Evaluated in a Peer-Reviewed Human Skin Study
- Last Chance to Turn $5K Into $90K? This $0.00055 Crypto Presale Joins the 5 Best Crypto Coins in 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share